RRM Prediction of Erythrocyte Band3 Protein as Alternative Receptor for SARS-CoV-2 Virus
Source abstract
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus causing a worldwide pandemic. It is infecting respiratory organs and, in more severe cases, the lungs, where it is infecting the human cells through the angiotensin-converting enzyme 2 (ACE2) receptor. In severe cases, it is characterized not only by difficulties in breathing through infected lungs, but also with disproportionally and, thus far, unexplained low levels of oxygen in the blood. Here, we propose that, besides the infection of respiratory organs through ACE2 receptors, there is an additional infection in the red blood cells (erythrocytes). There could be a possible for SARS-CoV-2 to pass through the alveoli membrane in the lungs and infect the red blood cells through another receptor. Using our own biophysical model, the Resonant Recognition Model, we propose that the red blood cell (RBC) Band3 protein on the surface of red blood cells is a possible entry point for the SARS-CoV-2 virus into red blood cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Erythrocyte Function and Pathophysiology · SARS-CoV-2 and COVID-19 Research · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
AMALNA Consulting, Black Rock, Melbourne, VIC 3193, Australia
College of Science, Engineering and Health, RMIT University, Melbourne, VIC 3000, Australia
QuantBioRes A/S - QBR A/S, 2860 Copenhagen, Denmark
References (24)
Show source-provided references
1. Makin, S. (2020, February 05). How Coronaviruses Cause Infection—from Colds to Deadly Pneumonia. Available online: https://www.scientificamerican.com/article/how-coronaviruses-cause-infection-from-colds-to-deadly-pneumonia1.10.1038/scientificamerican042020-1Xk7L801PdTJosULihfmM ↗
2. Couzin-Frankel, J. (2020, April 28). Why Don’t Some Coronavirus Patients Sense Their Alarmingly Low Oxygen Levels?. Available online: https://www.sciencemag.org/news/2020/04/why-don-t-some-coronavirus-patients-sense-their-alarmingly-low-oxygen-levels.10.1126/science.abc5107 ↗
3. Macromolecular Bioactivity: Is it Resonant Interaction between Macromolecules? -Theory and Applications10.1109/10.335859 ↗
4. Virtual spectroscopy for fun and profit
5. Cosic, I. (2012). The Resonant Recognition Model of Macromolecular Bioactivity: Theory and Applications, Birkhäuser Verlag.
6. Analysis of Tumor Necrosis Factor Function Using the Resonant Recognition Model10.1007/s12013-015-0716-3 ↗
7. Cosic, I., Paspaliaris, V., and Cosic, D. (2019). Analysis of Protein-Receptor on an Example of Leptin-Leptin Receptor Interaction Using the Resonant Recognition Model. Appl. Sci., 9.10.3390/app9235169 ↗
8. Studies on Protein-DNA Interactions Using the Resonant Recognition Model: Application to Repressors and Transforming Proteins10.1111/j.1432-1033.1992.tb16819.x ↗
9. Resonant Recognition Model and protein topography: Model studies with myoglobin, haemoglobin and lysozyme10.1111/j.1432-1033.1991.tb15993.x ↗
10. Application of the Resonant Recognition Model to the Study of Plasmodium Proteins Involved in Malaria Infection
11. Advances in methods for therapeutic peptide discovery, design and development10.2174/138920111796117436 ↗
12. Bioactive Peptide Design using the Resonant Recognition Model10.1186/1753-4631-1-7 ↗
13. In vitro inhibition of the actions of basic FGF by novel 16 amino acid peptides10.1007/BF01084262 ↗
14. Investigation Into the Cross-reactivity of Rabbit Antibodies Raised against Nonhomologous Pairs of Synthetic Peptides Derived from HIV-1 gp120 proteins10.1111/j.1399-3011.1998.tb00665.x ↗
15. Krsmanovic, V., Cosic, I., Biquard, J.M., and Hearn, M.T.W. (2001). Peptides immunologically related to known viral protein. (No. 6,294,174), U.S. Patent.
16. Achour, A., Biquard, J.M., Krsmanovic, V., M’Bika, J.P., Ficheux, D., Sikorska, M., and Cozzone, A.J. (2007). Induction of Human Immunodeficiency Virus (HIV-1) Envelope Specific Cell-Mediated Immunity by a Non-Homologus Synthetic Peptide. PLoS ONE, 2.10.1371/journal.pone.0001214 ↗
17. Investigation of cytotoxicity of negative control peptides versus bioactive peptides on skin cancer and normal cells: A comparative study10.4155/fmc.12.98 ↗
18. Istivan, T., Pirogova, E., Gan, E., Almansour, N., Coloe, P., and Cosic, I. (2011). Biological effects of a De Novo designed myxoma virus peptide analogue: Evaluation of cytotoxicity on tumor cells. PLoS ONE, 6.10.1371/journal.pone.0024809 ↗
19. Receptor recognition and cross-species infections of SARS coronavirus10.1016/j.antiviral.2013.08.014 ↗
20. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission10.1007/s11427-020-1637-5 ↗
21. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells10.1016/j.virol.2017.12.015 ↗
22. A Presenilin-like protease associated with Plasmodium falciparum micronemes is involved in erythrocyte invasion10.1016/j.molbiopara.2007.11.007 ↗
23. Gallagher, P.G. (2020, February 05). Hemolytic anemias: Red blood cell membrane and metabolic defects. Available online: https://www.semanticscholar.org/paper/HEMOLYTIC-ANEMIAS-%3A-RED-BLOOD-CELL-MEMBRANE-AND-Gallagher/0f01efe030314c2fadd42d007f0683721f854156.
24. Binding of glycophorins to Plasmodium falciparum merozoites10.1016/0166-6851(84)90019-7 ↗